000	00000nam 2200000zi 4500
001	9.939640
003	CaOODSP
005	20250305104117
006	m     o  d f
007	cr mn|||||||||
008	240621t20252025quca    ob   f000 0 eng d
020	|a9780660724652
040	|aCaOODSP|beng|erda|cCaOODSP
043	|an-cn---
086	1 |aEn84-391/2024E-PDF
245	00|aAssessment - benzotriazoles and benzothiazoles group.
264	1|aGatineau QC : |bEnvironment and Climate Change Canada, Health Canada, |cMarch 2025.
264	4|c©2025
300	|a1 online resource (ix, 133 pages) : |billustrations
336	|atext|btxt|2rdacontent
337	|acomputer|bc|2rdamedia
338	|aonline resource|bcr|2rdacarrier
500	|aCover title.
500	|aIssued also in French under title: Évaluation - groupe des benzotriazoles et des benzothiazoles.
504	|aIncludes bibliographical references (page 80-94).
520	|a"Pursuant to section 68 of the Canadian Environmental Protection Act, 1999 (CEPA) (Canada 1999), the Minister of the Environment and the Minister of Health have conducted an assessment on 15 substances, referred to collectively in this assessment as the Benzotriazoles and Benzothiazoles Group, to determine whether these 15 substances present or may present a risk to the environment or to human health. 10 of these 15 substances were identified as priorities for assessment as they met categorization criteria as described in ECCC, HC (modified 2017) and one substance was prioritized through other mechanisms"--Introduction, page 1.
650	0|aBenzothiazoles|zCanada.
650	0|aChemical industry|zCanada.
710	1 |aCanada. |bEnvironment and Climate Change Canada, |eissuing body.
710	1 |aCanada. |bHealth Canada, |eissuing body.
775	08|tÉvaluation - groupe des benzotriazoles et des benzothiazoles.|w(CaOODSP)9.939641
856	40|qPDF|s1.13 MB|uhttps://publications.gc.ca/collections/collection_2025/eccc/En84-391-2024-eng.pdf